Mitochondria play crucial role both in energetic and regulatory pathways within the cell. Inner mitochondrial membrane contains various ion channels, among which potassium channels are well described due to protective activities. Large conductance calcium activated potassium channel (BK Ca ) can be activated by channel openers such as NS1619 (1,3-dihydro-1-[2-hydroxy-5-(trifluoromethyl)phenyl]-5-(trifluoromethyl)-2H-benzimidazole-2-one). NS1619 can regulate functioning of endothelial cells EA.hy 926 in many aspects. In our study it was shown that NS1619 changes mitochondrial function both by decreasing mitochondrial potential and by increasing oxygen consumption probably due to activating BK Ca channels present in the inner mitochondrial membrane and thus promoting K + flux. Additionally NS1619 caused increase in calcium concentration within the endothelial cells. Calcium is well known regulator of many signaling pathways within the cells. Ionophore A23187 (1 µM) causes increase in calcium concentration, which subsequently increased nitric oxide (NO) production in EA.hy 926 cells via activation of nitric oxide synthase. Similar activity is proposed for NS1619. Along with these results it was observed that NS1619 increased coronary flow in isolated guinea pig hearts in NO dependent manner (100 µM L-NAME, inhibitor of nitric oxide synthase, partially reversed the effect of NS1619). It seems that NS1619 can have beneficial effect on endothelium via vasodilating activity, however, the exact mechanism which seems to involve both BK Ca channel activation and other places of action, needs further investigation. Cytoprotective properties of potassium channel openers (KCOs) have already been shown in several models of cell injury, mainly in ischemia-reperfusion-induced damage of cardiac muscle. The mechanism responsible for the observed cytoprotection as well as the relative contribution of potassium channels located in the plasma membrane and in the inner mitochondrial membrane to the beneficial effects exerted by KCOs remains unclear. This work demonstrates the cytoprotective properties of NS1619, an opener of large-conductance calcium-activated potassium channels (BK Ca channels), in C2C12 myoblasts injured by calcium ionophore A23187 treatment. Application of two BK Ca channel inhibitors, paxilline and iberiotoxin, abolished this cytoprotective effect. At the applied concentrations (10-100 µM), NS1619 increased the respiration rate of C2C12 cells in a dose-dependent manner. However 0.2 µM paxilline, which effectively abolished the protective effect of NS1619, failed to counteract the opener-induced increase in cellular respiration. This result indicates that the NS1619-mediated increase in the survival rate of A23187-treated C2C12 cells is distinct from its effect on mitochondrial functioning and suggests that activation of BK Ca channels in the plasma membrane is responsible for cytoprotection by NS1619. We describe the existence of a potassium ion transport mechanism in the mitochondrial inner membrane of plants. We found that substances known to modulate ATP-sensitive potassium channel (mitoK ATP ) activity influenced the bioenergetics of potato (Solanum tuberosum) tuber mitochondria, i.e. the rate of resting respiration and membrane potential. In isolated mitochondria, diazoxide (a potassium channel opener) was found to depolarize the mitochondrial membrane potential (measured with a TPP + -specific electrode) and to stimulate resting respiration. These effects were blocked by glibenclamide and ATP, potassium channel blockers, dependently on the presence of potassium ions in the incubation medium. We investigated monovalent cation (chloride salts) selectivity of the diazoxide-induced ATP-sensitive mitochondrial membrane depolarization. Pharmacological profile and immunoreactivity with specific antibodies indicate that the plant mitoK ATP channel belong to inward rectifier K + channel family -Kir.6.x. Our results suggest that an ATPsensitive potassium channel similar to that of mammalian mitochondria is present in plant mitochondria. This work was supported by the Polish Mitochondrial Network. University of Rochester Medical Center, Anesthesiology, USA E-mail: Andrew_wojtovich@urmc.rochester.edu
The mitochondrial ATP-sensitive K + channel (mitoK ATP ) protects the heart from damage induced by ischemia-reperfusion injury. Despite its central role in cardioprotection, the molecular identity of mitoK ATP remains controversial, and the validity of current methods to assay mitoK ATP activity is disputed. We sought to apply new and updated methods to investigate properties of the K + transporting component of mitoK ATP and its role in IPC. Using a thallium (Tl + ) sensitive fluorophore, a novel assay was developed to measure Tl + flux through mitoK ATP . With both this assay and the classical mitoK ATP osmotic swelling assay, four key observations were made: (i) The IC 50 for ATP-dependent channel inhibition was 4.5 µM. (ii) The EC 50 for UDP-dependent channel activation was 20 µM. (iii) In isolated mitochondria, mitoK ATP activity rapidly degraded with time, and this channel "run-down" was reversed by phosphatidylinositol-4,5-bisphosphate (PIP 2 ). (iv) The antidepressant fluoxetine (Prozac™) both inhibited mitoK ATP (IC 50 2.4 µM) and blocked mitoK ATP -dependent cardioprotection, while the related drug zimelidine was without effect. These findings are consistent with the hypothesis that the pore-forming subunit of mitoK ATP is an inward rectifying K + channel 
